It is currently unknown whether the reduction in RRM2 levels by ATR inhibition in leukemia cells occurs via a post-translational mechanism concerning protein stability and/or by a transcriptional mechanism downstream of E2F family members68, 69. The gene discussed is RRM2; the disease is leukemia.